• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Stroke . International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic

tetano

Editor, Senior Moderator
Stroke


. 2022 Apr 5;101161STROKEAHA121038250.
doi: 10.1161/STROKEAHA.121.038250. Online ahead of print.
International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic


Lauren A Beslow[SUP] 1 [/SUP], Shannon C Agner[SUP] 2 [/SUP], Jonathan D Santoro[SUP] 3 [/SUP], Dipak Ram[SUP] 4 [/SUP], Jenny L Wilson[SUP] 5 [/SUP], Dana Harrar[SUP] 6 [/SUP], Brian Appavu[SUP] 7 [/SUP], Stuart M Fraser[SUP] 8 [/SUP], Thomas Rossor[SUP] 9 [/SUP], Marcela D Torres[SUP] 10 [/SUP], Manoëlle Kossorotoff[SUP] 11 [/SUP], Yenny C Zuñiga Zambrano[SUP] 12 [/SUP], Marta Hernández-Chávez[SUP] 13 [/SUP], Sahar M A Hassanein[SUP] 14 [/SUP], Dimitrios Zafeiriou[SUP] 15 [/SUP], Michael M Dowling[SUP] 16 [/SUP], Ilona Kopyta[SUP] 17 [/SUP], Nicholas V Stence[SUP] 18 [/SUP], Timothy J Bernard[SUP] 19 [/SUP], Nomazulu Dlamini[SUP] 20 [/SUP], International Pediatric Stroke Study Group



Collaborators, Affiliations

Abstract

Background: Data from the early pandemic revealed that 0.62% of children hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an acute arterial ischemic stroke (AIS). In a larger cohort from June 2020 to December 2020, we sought to determine whether our initial point estimate was stable as the pandemic continued and to understand radiographic and laboratory data that may clarify mechanisms of pediatric AIS in the setting of SARS-CoV-2.
Methods: We surveyed international sites with pediatric stroke expertise to determine numbers of hospitalized SARS-CoV-2 patients <18 years, numbers of incident AIS cases among children (29 days to <18 years), frequency of SARS-CoV-2 testing for children with AIS, and numbers of childhood AIS cases positive for SARS-CoV-2 June 1 to December 31, 2020. Two stroke neurologists with 1 neuroradiologist determined whether SARS-CoV-2 was the main stroke risk factor, contributory, or incidental.
Results: Sixty-one centers from 21 countries provided AIS data. Forty-eight centers (78.7%) provided SARS-CoV-2 hospitalization data. SARS-CoV-2 testing was performed in 335/373 acute AIS cases (89.8%) compared with 99/166 (59.6%) in March to May 2020, P<0.0001. Twenty-three of 335 AIS cases tested (6.9%) were positive for SARS-CoV-2 compared with 6/99 tested (6.1%) in March to May 2020, P=0.78. Of the 22 of 23 AIS cases with SARS-CoV-2 in whom we could collect additional data, SARS-CoV-2 was the main stroke risk factor in 6 (3 with arteritis/vasculitis, 3 with focal cerebral arteriopathy), a contributory factor in 13, and incidental in 3. Elevated inflammatory markers were common, occurring in 17 (77.3%). From centers with SARS-CoV-2 hospitalization data, of 7231 pediatric patients hospitalized with SARS-CoV-2, 23 had AIS (0.32%) compared with 6/971 (0.62%) from March to May 2020, P=0.14.
Conclusions: The risk of AIS among children hospitalized with SARS-CoV-2 appeared stable compared with our earlier estimate. Among children in whom SARS-CoV-2 was considered the main stroke risk factor, inflammatory arteriopathies were the stroke mechanism.

Keywords: arteriopathy; child; hospitalization; ischemic stroke; risk factors.
 
Back
Top Bottom